Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?
Molbio Diagnostics aims to secure ₹200 crore to enhance its capital expenditures through a new issuance of shares. In tandem, the firm intends to reduce promoter stake by generating ₹740 crore via an offer for sale. With six manufacturing sites worldwide, the company caters to over ninety nations and has seen substantial revenue growth attributed […]
As banks shrink microfinance books, bigger MFIs prepare to grab the gap
Large microfinance companies including Muthoot Microfin and Satin Creditcare have raised their growth forecasts as private banks, small finance banks and smaller MFIs scale back lending. Improving asset quality is also supporting expansion by larger, well-capitalised microfinance lenders.